Guangdong, China
Business Type:
Manufacturer/Factory
Number of Employees:
120
Year of Establishment:
2005-03-16
Management System Certification:
ISO9001:2008, ISO13485:2003 certificate
OEM/ODM Service
Sample Available
U.S. Warehouse

Antibcterial Dressing, Antibacterial Dressing, Silver Surgical Dressing manufacturer / supplier in China, offering Antibacterial Silver Alginate Dressing CE FDA 510k, FDA Approved Tampons New Premium Ent Hemostatic Sponge Nasal Dressing PVA String Surgical Tampon, Foryou Medical Suntouch Hemostatic Nose Tampon Merocele Epistaxis Medical PVA Sponge Nasal Dressing String and so on.

Gold Member Since 2012
Audited Supplier

Antibacterial Silver Alginate Dressing CE FDA 510k

Get Latest Price
Purchase Qty. / Reference FOB Price
10,000-29,999 Pieces US $0.6
30,000+ Pieces US $0.5
Production Capacity: 1, 000, 000 PCS/Year
Transport Package: Aluminum Foil Bag, Paper/Poly Bag
Payment Terms: T/T, Western Union, Paypal
Type: Silver Wound Dressing
Material: Non-woven Fabric
Certification: FDA
Ethylene Oxide Sterilization: Gamma
Quality Guarantee Period: Two Years
Group: All

You Might Also Like

Loading...

Basic Info

Model NO.: SAD0003
Logo Printing: With Logo Printing
Name: Silver Alginate Dressing
Size: 5X5cm, 10X10cm, 15X15cm, 12.5X12.5cm
Feature1: Accelerate Epithelization
Feature2: Antibacterial Effect
Trademark: LUOFUCON
Specification: 10 pcs per package
Origin: Huizhou, Guangdong, China
HS Code: 3005901000

Product Description

Product Description:

LUOFUCON®Silver Alginate Dressing is a non-woven pad composed of calcium alginate and silver particles. The silver content is 50µg/100 cm2. The silver particles are in the form of encapsulated metallic silver, which is very stable and won't be oxidized even on exposure to light.
LUOFUCON® Silver Alginate Dressing is proved to have broad spectrum antibacterial effect , based on in vitro laboratory testing.
 
1. Silver Release
Figure1 shows that LUOFUCON® Silver Alginate Dressing leaches about 57% of the total silver during the first 24 hours, and 30%, 24% of its total silver during 24-48, 48-72 hours, respectively.
The release profiles indicates that the release of silver from the dressing is well controlled.
 
Note:
Two pieces of the dressing in the size of 10 x 10 cm were used in this test. The test was performed by China National Analytical Center at Guangzhou.
 
LUOFUCON® Silver Alginate Dressing leaches about 57% of the total silver during the first 24 hours, and 30%, 24% of its total silver during 24-48, 48-72 hours, respectively.
The release profiles indicates that the release of silver from the dressing is well controlled.
 
Antibacterial Effectiveness Test
AATCC 100-2004 only specifies the use of one Gram-positive and one Gram-negative bacteria. However, we tested six clinical-relevant bacteria ( 3 Gram-positive and 3 Gram-negative bacteria) for the evaluation of antibacterial effectiveness.

Test Organism
Test Method
Enterococcus faecalisATCC 29219Dressing specimens and controls were tested under simulated use conditions for seven days. During this time, test articles were kept moistened daily with phosphate buffered water containing 10% Fetal Bovine Serum to simulate daily use. The antibacterial activity testing was performed with an inoculum challenge of more than 106 CFU total.
Escherichia coliATCC 8739
Klebsiella pneumoniaeATCC 4352
Pseudomonas aeruginosaATCC 9027
Staphylococcus aureusATCC 6538
Streptococcus pyogenesATCC 19615

 
Table 1: 1 Day Antibacterial Effectiveness
 
  1 Day
 Replicate 1Replicate 2Replicate 3
Staphylococcus aureus>4.0>4.1>4.1
Streptococcus pyogenes>4.4>4.4>4.3
Enterococcus faecalis>4.3>4.2>4.3
Escherichia coli>4.2>4.2>4.13
Klebsiella pneumoniae>4.1>4.0>4.1
Pseudomonas aeruginosa>4.1>4.1>4.1

 
 Table 2: 7 Days Antibacterial Effectiveness
 
7 Day
 Replicate 1Replicate 2Replicate 3
Staphylococcus aureus>4.0>4.0>4.0
Streptococcus pyogenes>4.1>4.1>4.1
Enterococcus faecalis2.11.62.6
Escherichia coli>4.3>4.3>4.3
Klebsiella pneumoniae>4.2>4.2>4.2
Pseudomonas aeruginosa>4.0>4.0>4.0

 
2.3 Additional Study
Besides the six clinical-relevant bacteria above, we made an additional study for one drug-resistant bacteria(MRSA) and one fungus(Candida albicans).
 

Send your message to this supplier

*From:
*To:
avatar Ms. Anna Wang
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now